UK medical cannabis prescriptions are increasing, but awareness is lacking
Approaching the sixth anniversary of specially trained doctors being allowed to write prescriptions in the United Kingdom, private…
News October 24
Latest In: Europe
Germany’s medical cannabis sales to exceed $455M in 2024, report says
Medical cannabis sales in Germany are on pace to exceed a record 420 million euros (roughly $455.2 million)…
News October 17
Poland medical cannabis import limits set to double in 2024
Poland is set to significantly increase the import cap on medical cannabis based on continually expanding demand in…
News October 11
IM Cannabis announces $1.6 million private placement to repay loan
Medical marijuana company IM Cannabis Corp. is planning a non-brokered private placement offering of up to $1.6 million…
News October 10
Dutch medical marijuana producer Bedrocan returning to Canada
Medical marijuana producer Bedrocan International is returning to the Canadian market through the purchase of a facility in…
News October 10
14 licenses for cannabis social clubs granted in 4 German federal states
The number of applications and licenses granted for cannabis cultivation social clubs in Germany continued to grow throughout…
News October 3
Second phase of German adult-use marijuana market launch in jeopardy
Germany’s long-anticipated “Pillar 2,” which would launch adult-use marijuana sales as part of a limited-duration pilot project, is…
News September 19
Cannabis producer Organigram closes on second tranche, reaps CA$41.5 million
A British American Tobacco subsidiary acquired roughly 4.4 million Organigram common shares and 8.5 million Class A preferred…
News September 3
David Klein retiring as CEO of Canadian cannabis operator Canopy Growth
David Klein, who joined Canopy Growth Corp. as CEO in 2020, will retire at the end of company’s…
News August 16
Is the future of cannabis in Europe? Q&A with Bloomwell CEO Niklas Kouparanis
Germany’s recreational cannabis market has limited opportunity, but Bloomwell Group's Niklas Kouparanis is bullish on the medical market.
News July 30
Latest Sponsored
